HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,221 | +5.2% | 449 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $38,228 | +2.9% | 449 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $37,155 | +51.4% | 449 | +43.9% | 0.00% | 0.0% |
Q4 2022 | $24,539 | +6.7% | 312 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $23,000 | +35.3% | 312 | +17.3% | 0.00% | 0.0% |
Q2 2022 | $17,000 | +183.3% | 266 | +186.0% | 0.00% | – |
Q1 2022 | $6,000 | +100.0% | 93 | +52.5% | 0.00% | – |
Q4 2021 | $3,000 | -85.7% | 61 | -79.3% | 0.00% | -100.0% |
Q3 2021 | $21,000 | +320.0% | 294 | +286.8% | 0.00% | – |
Q2 2021 | $5,000 | +150.0% | 76 | +347.1% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 17 | -34.6% | 0.00% | – |
Q4 2020 | $3,000 | +200.0% | 26 | +116.7% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 12 | -36.8% | 0.00% | – |
Q2 2020 | $2,000 | -93.5% | 19 | -93.9% | 0.00% | -100.0% |
Q1 2020 | $31,000 | -13.9% | 312 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $36,000 | -7.7% | 312 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $39,000 | +2.6% | 312 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $38,000 | +40.7% | 312 | 0.0% | 0.00% | +50.0% |
Q1 2019 | $27,000 | -15.6% | 312 | -2.2% | 0.00% | -33.3% |
Q4 2018 | $32,000 | -13.5% | 319 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $37,000 | +27.6% | 319 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $29,000 | +26.1% | 319 | +2.2% | 0.00% | 0.0% |
Q1 2018 | $23,000 | – | 312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |